Dolutegravir丨CAS 1051375-16-6

Dolutegravir丨CAS 1051375-16-6
Product Introduction:
Catalog No.: SS128204
CAS No.: 1051375-16-6
Purity (HPLC, %a/a): 99.0%min
Product Name: Dolutegravir
Molecular Formula: C20H19F2N3O5
Molecular Weight: 419.38
Synonym(s): GSK1349572
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of dolutegravir丨cas 1051375-16-6 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications of Dolutegravir丨CAS 1051375-16-6

 

Appearance

Pale-yellow or off-white powder

Purity (HPLC, %a/a)

99.0% min

Identification (HPLC)

Retention time consistent with reference substance

Water (K.F, %w/w)

0.5% max

 

 

 

 

Applications

1. HIV Treatment

Dolutegravir丨CAS 1051375-16-6 is a key antiretroviral medication used in the treatment of HIV-1 infection.

It is a potent integrase strand transfer inhibitor (INSTI) that blocks the HIV integrase enzyme, preventing viral DNA from integrating into the host genome.

Commonly used as part of combination antiretroviral therapy (cART) or highly active antiretroviral therapy (HAART).

Approved for both treatment-naive and treatment-experienced patients.

2. Combination Drug Formulations

Dolutegravir is often combined with other antiretrovirals, such as abacavir and lamivudine, in fixed-dose combinations (e.g., Triumeq), improving patient compliance and treatment efficacy.

3. Research and Development

Used in clinical and pharmaceutical research focused on HIV treatment regimens.

Explored for potential use in long-acting formulations and combination therapies.


 

Benefits

✅ High Potency and Efficacy

Strong antiviral activity against HIV-1, even against some strains resistant to other integrase inhibitors.

✅ Favorable Safety Profile

Generally well-tolerated with fewer side effects compared to earlier HIV drugs.

Low potential for drug-drug interactions.

✅ Once-Daily Dosing

Long plasma half-life allows for convenient once-daily dosing without the need for pharmacokinetic boosters.

✅ Resistance Profile

High genetic barrier to resistance; effective in patients with resistance to other classes of HIV drugs.


 

Summary

Dolutegravir丨CAS 1051375-16-6 is a frontline antiretroviral drug widely used in the treatment of HIV-1 infection. Its role as a potent integrase inhibitor with high efficacy, favorable safety profile, and convenient dosing makes it a cornerstone in modern HIV therapy and a vital component of combination antiretroviral regimens.

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us